MedPath

Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy

Not Applicable
Completed
Conditions
Iron Deficiency Anemia of Pregnancy
Registration Number
NCT03456258
Lead Sponsor
Ain Shams University
Brief Summary

The study aims to compare the efficacy and the safety of Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy.

Detailed Description

The study was done at ainshams university maternity hospital on 100 pregnant women randomized in two groups .

Group one lactoferrin group Group two ferrous sulphate group

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • pregnant women from 20 to 40 years
  • iron deficiency anemia (mild and moderate)
  • gestational age 13 to 26 weeks
  • singleton viable pregnancy.
Exclusion Criteria
  • history of anemia due to chronic blood loss
  • hemolytic anemia
  • severe anemia
  • history of peptic ulcer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
hemoglobin level2 months

Measure hemoglobin level two months after treatment

Secondary Outcome Measures
NameTimeMethod
Serum ferritin2 months

Measure serum ferritin level

Trial Locations

Locations (1)

Ainshams maternity hospital

🇪🇬

Cairo, Abbasia, Egypt

Ainshams maternity hospital
🇪🇬Cairo, Abbasia, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.